- Home
- WSFS vs TVTX Comparison
WSFS vs TVTX Comparison
Compare WSFS & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSFS
- TVTX
- Stock Information
- Founded
- WSFS 1980
- TVTX 2008
- Country
- WSFS United States
- TVTX United States
- Employees
- WSFS N/A
- TVTX N/A
- Industry
- WSFS Major Banks
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- WSFS Finance
- TVTX Health Care
- Exchange
- WSFS Nasdaq
- TVTX Nasdaq
- Market Cap
- WSFS 3.0B
- TVTX 3.1B
- IPO Year
- WSFS N/A
- TVTX N/A
- Fundamental
- Price
- WSFS $55.77
- TVTX $35.45
- Analyst Decision
- WSFS Strong Buy
- TVTX Strong Buy
- Analyst Count
- WSFS 4
- TVTX 15
- Target Price
- WSFS $66.25
- TVTX $37.21
- AVG Volume (30 Days)
- WSFS 369.7K
- TVTX 2.0M
- Earning Date
- WSFS 10-23-2025
- TVTX 10-30-2025
- Dividend Yield
- WSFS 1.22%
- TVTX N/A
- EPS Growth
- WSFS 9.94
- TVTX N/A
- EPS
- WSFS 4.83
- TVTX N/A
- Revenue
- WSFS $1,011,052,000.00
- TVTX $435,826,000.00
- Revenue This Year
- WSFS N/A
- TVTX $108.68
- Revenue Next Year
- WSFS $17.49
- TVTX $40.23
- P/E Ratio
- WSFS $11.56
- TVTX N/A
- Revenue Growth
- WSFS 4.02
- TVTX 114.22
- 52 Week Low
- WSFS $42.44
- TVTX $12.91
- 52 Week High
- WSFS $61.10
- TVTX $37.50
- Technical
- Relative Strength Index (RSI)
- WSFS 57.36
- TVTX 61.14
- Support Level
- WSFS $53.96
- TVTX $34.18
- Resistance Level
- WSFS $57.11
- TVTX $36.87
- Average True Range (ATR)
- WSFS 1.43
- TVTX 1.86
- MACD
- WSFS 0.27
- TVTX -0.25
- Stochastic Oscillator
- WSFS 76.36
- TVTX 60.98
About WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.